STOCK TITAN
  1. Home
  2. News
  3. PETVW

PetVivo Holdings Inc - PETVW STOCK NEWS

Welcome to our dedicated news page for PetVivo Holdings (Ticker: PETVW), a resource for investors and traders seeking the latest updates and insights on PetVivo Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PetVivo Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PetVivo Holdings's position in the market.

News
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA
Rhea-AI Summary
PetVivo Holdings, Inc. will be a Silver Sponsor at the IVAPM Pain Management Forum to exhibit its lead product, Spryng™ with OsteoCushion™ Technology. The clinical studies on Spryng show significant improvements in dogs with joint diseases, making it a promising veterinary medical device for osteoarthritis management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7%
Tags
none
-
News
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA
Rhea-AI Summary
PetVivo Holdings, Inc. will showcase its innovative veterinary medical device, Spryng, with OsteoCushion Technology at the ACVSMR Symposium. Spryng aims to manage joint pain in pets by promoting proper joint mechanics. CEO John Lai expresses excitement for the opportunity to present Spryng at the event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
none
-
News
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA
Rhea-AI Summary
PetVivo Holdings, Inc. announces its participation in the ACVSMR Symposium to showcase its lead product, SPRYNG™ with OsteoCushion™ Technology, aimed at managing joint pain in pets. The event will be held from April 11th to April 13th, 2024, in Naples, Florida.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
none
News
Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer
Rhea-AI Summary
PetVivo Holdings, Inc. appoints Garry Lowenthal as the new Chief Financial Officer, bringing over 25 years of extensive experience in finance management and operations. Mr. Lowenthal's background includes leading equity capital raising transactions for private and public companies, serving on the national board of Financial Executives International, and working for top CPA/Consulting firms like PricewaterhouseCoopers and Deloitte.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
-
News
PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV
Rhea-AI Summary
PetVivo Holdings, Inc. dual lists on Upstream's global securities trading app, providing digital-first investors worldwide with streamlined access to PETV shares. The company's free NFT commemorating the listing is available for all Upstream participants. Non-U.S. investors can deposit or trade PETV securities on Upstream, with trading starting after the first offer is placed. The market operates 5 days a week, 20 hours a day, offering real-time trading and settlement with transparent orderbooks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
none
-
News
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California
Rhea-AI Summary
PetVivo Holdings, Inc. announced the successful completion of the first cohort of dogs in a clinical study focusing on the benefits of an intra-articular injection of collagen-elastin hydrogel microparticles for dogs with osteoarthritis. The study showed promising results with significant improvements in CBPI scores, hip extension, visual lameness scores, and quality of life assessments. Spryng™ with OsteoCushion™ Technology appears to be a viable option for managing coxofemoral joint osteoarthritis in companion animals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.65%
Tags
clinical trial
News
PetVivo Holdings, Inc. Approved to Dual List on Upstream
Rhea-AI Summary
PetVivo Holdings, Inc. (PETV) to dual list shares on Upstream for global trading starting March 5, 2024. Shareholders to receive commemorative NFT. Upstream offers real-time trading, transparent orderbook, and digital collectibles for participants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA
Rhea-AI Summary
PetVivo Holdings, Inc. will showcase its innovative veterinary medical device, SPRYNG™ with OsteoCushion™ Technology, at the Western Veterinary Conference. The conference, hosting over 15,000 participants, offers a platform for PetVivo to engage with industry professionals and promote its joint pain management solution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
none
-
News
PetVivo Reports Third Quarter of Fiscal 2024 Financial Results
Rhea-AI Summary
PetVivo Holdings, Inc. (Nasdaq: PETV) announces financial results for the third quarter of 2024, highlighting a multi-distribution sales strategy and the addition of a new Board member. The company raised $1.2 million in a private offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
earnings
News
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
Rhea-AI Summary
PetVivo Holdings, Inc. announced the release of the results of a clinical study conducted by Inotiv, Inc., which examined the safety of intra-articular injections of collagen-elastin hydrogel microparticulates (Spryng™ with OsteoCushion™ Technology) into the joints of cats. The study demonstrated the excellent safety profile of Spryng when injected into 40 joints across 10 individual cats, showing similar results to a benign control in terms of incidences of lameness, joint swelling, or pain after injection.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.88%
Tags
clinical trial
Stock PETVW logo
PetVivo Holdings Inc

Nasdaq:PETVW

PETVW Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

PETVW Stock Data

11.85M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Minneapolis

About PETVW

petvivo, inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. petvivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. petvivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. petvivo, inc, gel-del technologies, inc. and cosmetalife a corporation are all wholly-owned subsidiaries of petvivo holdings, inc.